Kazuki Hirose

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Determination of 90Sr in highly radioactive aqueous samples via conversion to a kinetically stable 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid complex followed by concentration-separation-fractionation based on capillary electrophoresis-liquid scintillation.

Determination of 90Sr in highly radioactive aqueous samples via conversion to a kinetically stable 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid complex followed by concentration-separation-fractionation based on capillary electrophoresis-liquid scintillation.

Journal: Analytica chimica acta

Published: December 06, 2023

Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study.

Early responders within seven days of dupilumab treatment for severe asthma evaluated by patient-reported outcome: a pilot study.

Journal: Multidisciplinary respiratory medicine

Published: November 21, 2020

Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.

Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.

Journal: Thoracic cancer

Published: September 16, 2020

Drug-induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis.

Drug-induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis.

Journal: Respirology case reports

Published: July 17, 2020

IgG4-related lung disease progressing to respiratory failure.

IgG4-related lung disease progressing to respiratory failure.

Journal: Respirology case reports

Published: June 25, 2020

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer.

Atezolizumab in combination with carboplatin and etoposide for heavily treated small cell lung cancer.

Journal: Thoracic cancer

Published: June 12, 2020

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation-A Case Report and a Review of the Literature.

Osimertinib-Associated Toxic Epidermal Necrolysis in a Lung Cancer Patient Harboring an EGFR Mutation-A Case Report and a Review of the Literature.

Journal: Medicina (Kaunas, Lithuania)

Published: June 12, 2020

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.

Journal: Scientific reports

Published: May 30, 2020

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10.

Bioconversion From Docosahexaenoic Acid to Eicosapentaenoic Acid in the Marine Bacterium Shewanella livingstonensis Ac10.

Journal: Frontiers in microbiology

Published: March 09, 2020

Vogt-Koyanagi-Harada disease during chemoimmunotherapy for non-small cell lung cancer.

Vogt-Koyanagi-Harada disease during chemoimmunotherapy for non-small cell lung cancer.

Journal: Respirology case reports

Published: January 31, 2020

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis.

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis.

Journal: Journal of clinical medicine

Published: January 31, 2020

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.

Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.

Journal: Cancers

Published: February 20, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026